Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

AHRQ: Consider Cost But Do Not Limit Coverage

Posted Apr 07 2009 11:36pm
At its April 3rd meeting, theNational Advisory Council of the Agency for Healthcare Research and Qualitysaid that the cost of drugs and devices should be considered when researching comparative effectiveness, but cost should not be used to deny or limit coverage.  
The Council apparently wants to focus primarily on clinical outcomes and consider cost as a much less weighty factor.  Apparently, AHRQ is too nice to beNICE.
Post a comment
Write a comment:

Related Searches